2018, FDA Approval, Pharmacokinetics and Small Molecule

Metabolism of 2023 FDA Approved Small Molecules – PART 1

Metabolite Tales Blog

JANUARY 23, 2024

Metabolism of 2023 FDA Approved Small Molecules – PART 1 By Julia Shanu-Wilson 2023 was a fruitful year for drug approvals by the FDA, with a crop of 34 small molecules out of a total of 55 new drugs [1]. References [1] 2023 Novel Small Molecule FDA Drug Approvals.

Small Molecule

Small Molecule FDA Approval FDA Pharmacokinetics

Metabolism of 2022 FDA approved small molecule drugs PART 2

Metabolite Tales Blog

APRIL 4, 2023

Metabolism of 2022 FDA approved small molecule drugs part 2 Mixing it Up By Julia Shanu-Wilson In Part 1 of this topic we looked at metabolism of the small molecule drugs approved by the FDA in 2022 that were mediated by CYP3A4. link] [2] Zhang and Tang, 2018. 2018 Sep;8(5):721-732.

Small Molecule

Small Molecule FDA Approval FDA Drugs

The evolution of the RNA therapeutics landscape

Drug Discovery World

JULY 8, 2024

With the knowledge that RNA can adopt a diverse range of structural shapes, we can now develop therapeutics using RNAs 3D structure, similar to creating antibody therapies or small molecules that can target surfaces on proteins. These are critical attributes for acute care applications.

RNA

RNA Small Molecule Vaccine FDA Approval

Drug Discovery Digest

Metabolism of 2023 FDA Approved Small Molecules – PART 1

Metabolism of 2022 FDA approved small molecule drugs PART 2

The evolution of the RNA therapeutics landscape

Stay Connected